Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

B5182

Sigma-Aldrich

7-Benzyloxyquinoline

≥99% (HPLC), solid

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C16H13NO
CAS Number:
Molecular Weight:
235.28
MDL number:
UNSPSC Code:
12161501
PubChem Substance ID:

Quality Level

Assay

≥99% (HPLC)

form

solid

storage temp.

−20°C

SMILES string

C(Oc1ccc2cccnc2c1)c3ccccc3

InChI

1S/C16H13NO/c1-2-5-13(6-3-1)12-18-15-9-8-14-7-4-10-17-16(14)11-15/h1-11H,12H2

InChI key

SIDLHXXVIBTSJZ-UHFFFAOYSA-N

Biochem/physiol Actions

Fluorogenic substrate for CYP3A4.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bikash Dangi et al.
Archives of biochemistry and biophysics, 698, 108677-108677 (2020-11-17)
We investigate the effect of the alcohol-induced increase in the content of CYP2E1 in human liver microsomes (HLM) on the function of CYP3A4. Membrane incorporation of the purified CYP2E1 into HLM considerably increases the rate of metabolism of 7-benzyloxyquinoline (BQ)
M N Lombardo et al.
Drug metabolism and disposition: the biological fate of chemicals, 47(9), 995-1003 (2019-06-16)
Pharmacokinetic/pharmacodynamic properties are strongly correlated with the in vivo efficacy of antibiotics. Propargyl-linked antifolates, a novel class of antibiotics, demonstrate potent antibacterial activity against both Gram-positive and Gram-negative pathogenic bacteria, including multidrug-resistant Staphylococcus aureus Here, we report our efforts to
Anup Aggarwal et al.
Cell, 170(2), 249-259 (2017-07-04)
Widespread resistance to first-line TB drugs is a major problem that will likely only be resolved through the development of new drugs with novel mechanisms of action. We have used structure-guided methods to develop a lead molecule that targets the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service